Drugs/Products That May Increase Cancer Risk
46 - 60 of
112 Results
Sort Results:
Article:
Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for relapsing forms of multiple sclerosis (MS)
February 2014
Commentary:
FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions
January 2014